Ixazomib shortage — PE supply status & alternatives

Ixazomib

—

🇦🇺 AUST R 260935 · Takeda Pharmaceuticals Australia Pty Ltd

In supply · Australia

Ninlaro

In supply · 🇦🇺 Australia · short in🌐 PE🌐 RO

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Ixazomib
Brand names	Ninlaro
Therapeutic category	Auto-created by ANMDMR — Notificari discontinuitate medicamente (Romania) scraper

Marketing-authorisation holders	Takeda Pharmaceuticals Australia Pty Ltd

Registrations on file	3

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🌐

DIGEMID · 1h ago

Medium

🌐

ANMDMR · 2h ago

Sortage

Verified timeline regulator events

🌐 25 June 2026

shortage reported

🌐 8 Nov 2022

medium reported

🌐 24 Feb 2020

medium reported

Sources official regulators

🌐

DIGEMID

verified 1h ago

verify ↗

🌐

ANMDMR

verified 2h ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders3 registrations · 1 MA holder

Product	Strength	Form	Market	MA holder	Status
NINLARO ixazomib	3mg	—	🇦🇺 AU	Takeda Pharmaceuticals Australia Pty Ltd	Active
NINLARO ixazomib	2.3mg	—	🇦🇺 AU	Takeda Pharmaceuticals Australia Pty Ltd	Active
NINLARO ixazomib	4mg	—	🇦🇺 AU	Takeda Pharmaceuticals Australia Pty Ltd	Active

Mederti Drug Report

Generated 5 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.